Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome

Charlotte Treldal, Cecilie Bang Jacobsen, Stine Mogensen, Mette Rasmussen, Jette Jacobsen, Janne Petersen, Anne Marie Lynge Pedersen, Ove Andersen

28 Citationer (Scopus)

Abstract

OBJECTIVE: Patients with burning mouth syndrome (BMS) often represent a clinical challenge as available agents for symptomatic treatment are few and often ineffective. The aim was to evaluate the effect of a bupivacaine lozenge on oral mucosal pain, xerostomia and taste alterations in patients with BMS.

METHODS: Eighteen 18 patients (4 men and 14 women) aged 39-71 years with BMS were included in this randomized, double-blinded, placebo-controlled, cross-over trial. Lozenges (containing bupivacaine or placebo) were administrated three times a day for two weeks for two separate treatment periods. Assessment of oral mucosal pain, xerostomia and taste alterations was performed in a patient diary on a visual analogue scale (ranging from 0-100 mm) before and after the lozenge was dissolved.

RESULTS: The bupivacaine lozenge significantly reduced the burning oral pain (p<0.001), increased the sense of taste disturbances (p<0.001), and had no impact on xerostomia, when adjusted for the treatment period.

CONCLUSIONS: Our results indicate that the bupivacaine lozenge offers a novel therapeutic modality to patients with BMS, although without alleviating effect on the associated symptoms, taste alterations and xerostomia. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftOral Diseases
Vol/bind22
Udgave nummer2
Sider (fra-til)123-131
ISSN1354-523X
DOI
StatusUdgivet - mar. 2016

Fingeraftryk

Dyk ned i forskningsemnerne om 'Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome'. Sammen danner de et unikt fingeraftryk.

Citationsformater